Axsome Therapeutics, Inc.
AXSM
Κατάταξη σε μετοχές
#2371
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to... Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
Τιμή μετοχής
$155.46
Κεφαλαιοποίηση
$8.14B
Αλλαγή (1 ημέρα)
-0.55%
Αλλαγή (1 έτος)
19.84%
Χώρα
US
Εμπόριο Axsome Therapeutics, Inc. (AXSM)
Κατηγορία
Healthcare
Ιστορικό τιμής μετοχής για την Axsome Therapeutics, Inc. (AXSM)
Υψηλότερη τιμή κλεισίματος: $165.94 στις 2026-10-01
Χαμηλότερη τιμή κλεισίματος: $8.99 στις 2015-11-01
Χαμηλότερη τιμή κλεισίματος: $8.99 στις 2015-11-01
Ιστορικό τιμής μετοχής της Axsome Therapeutics, Inc. από 2015 έως 2026
Ετήσια απόδοση τιμής μετοχής
| Έτος | Απόδοση |
|---|---|
| 2026 (TTM) | 25.39% |
| 2025 | 62.10% |
| 2024 | 26.95% |
| 2023 | -4.24% |
| 2022 | 118.74% |
| 2021 | -56.59% |
| 2020 | 11.03% |
| 2019 | 2,538.67% |
| 2018 | -44.64% |
| 2017 | -23.67% |
| 2016 | -25.67% |
| 2015 | 0.00% |
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Τιμή μετοχής | Μεταβολή 1Έτ% | Χώρα |
|---|---|---|---|
| $535.96 | 25.68% |
US
|
|
| $186.23 | 593.59% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $892.29 | 9.59% |
NL
|
